Organization Profile

You just read:

Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV)

News provided by

Eiger BioPharmaceuticals, Inc.

Apr 27, 2015, 09:40 ET